Acceleron Pharma (United States)

274 papers and 12.3k indexed citations i.

About

In recent decades, authors affiliated with Acceleron Pharma (United States) have published 274 papers, which have received a total of 12.3k indexed citations. Scholars at this organization have produced 117 papers in Molecular Biology, 65 papers in Genetics and 61 papers in Hematology on the topics of TGF-β signaling in diseases (42 papers), Hemoglobinopathies and Related Disorders (36 papers) and Muscle Physiology and Disorders (31 papers). Their work is cited by papers focused on Molecular Biology (4.5k citations), Endocrine and Autonomic Systems (2.5k citations) and Physiology (2.4k citations). Authors at Acceleron Pharma (United States) collaborate with scholars in United States, Italy and China and have published in prestigious journals including New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry. Some of Acceleron Pharma (United States)'s most productive authors include Nae J. Dun, Jasbir Seehra, Ravindra Kumar, Jun Yang, J.K. Chang, Mark Ensor, John S. Bomalaski, Mike A. Clark, Frederick W. Holtsberg and R. Scott Pearsall.

In The Last Decade

Fields of papers published by authors at Acceleron Pharma (United States)

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Acceleron Pharma (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Acceleron Pharma (United States) at the time of their publication.

Countries citing scholars working at Acceleron Pharma (United States)

Since Specialization

Citations

This map shows the geographic impact of research produced by authors working at Acceleron Pharma (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Acceleron Pharma (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Acceleron Pharma (United States) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Breakdown of academic impact, for scholars at Veterans Medical Research Foundation of San Diego Breakdown of academic impact, for scholars at Yellowstone National Park Breakdown of academic impact, for scholars at Biotechnologie et Signalisation Cellulaire Breakdown of academic impact, for scholars at TCL (China) Breakdown of academic impact, for scholars at Génomique Fonctionnelle des Tumeurs Solides Breakdown of academic impact, for scholars at Boehringer Ingelheim (France) Breakdown of academic impact, for scholars at Spencer Foundation Breakdown of academic impact, for scholars at NatureServe